# US 8,569,074 B2 · Analyte-releasing beads and use thereof in quantitative elispot or fluorispot assay > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 8,569,074 B2 - Document ID: US8569074B2 - Status: Granted - Kind: B2 - Application number: 12/298,626 - Filed: 2007-04-30 - Published: 2010-11-25 - Granted: 2013-10-29 - Earliest claimed: 2006-04-28 - Assignees: University of Rochester - Applicants: Martin S. Zand; Alicia D. Henn - Inventors: Martin S. Zand; Alicia D. Henn - Web page: https://patentgrep.com/patent/US8569074B2 ## CPC - G01N 33/543: with an insoluble carrier for immobilising immunochemicals - G01N 33/54306: {Solid-phase reaction mechanisms} - G01N 33/54326: {Magnetic particles} - G01N 33/56972: {White blood cells} - G01N 33/6854: {Immunoglobulins} - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) ## Abstract A method of quantifying analyte secreted by a cell or released from a drug delivery vehicle, typically by ELISpot or fluorispot assay is described. Quantification is possible through the use of an analyte-releasing reagent that includes a bead and the analyte releasably bound to the bead, or a container pre-spotted with analyte released from the reagent. The reagent or pre-spotted containers can be used to provide a standard curve for release of the analyte. By detecting analyte secreted by one or more cells or drug released by a drug delivery vehicle, and comparing the detected analyte to the standard curve, it is possible to quantify the amount of analyte released by the one or more cells or drug released by the drug delivery vehicle. Kits and reagents for practicing the methods of the present invention are also disclosed. ## Claims ### Claim 1 A method of quantifying cellular secretion of an analyte comprising: providing a container comprising a surface capable of binding an analyte; providing a standard curve for release of the analyte into a container by one or more analyte-releasing reagents that comprise a bead and the analyte releasably bound to the bead, the container comprising a surface capable of binding the analyte; introducing into the provided container one or more cells that secrete the analyte; detecting the presence of analyte bound to the surface of the container into which the one or more cells were introduced; and comparing the detected analyte to the standard curve to quantify the amount of analyte released by the one or more cells. ### Claim 2 (depends on 1) The method according to claim 1, wherein said providing a standard curve comprises detecting analyte released by three or more analyte-releasing reagents each characterized, on average, by a different amount of bound analyte that is between about 0.01 picograms up to about 10 micrograms. ### Claim 3 (depends on 1) The method according to claim 1 wherein the bead further comprises a linker molecule comprising a first portion tethered to the bead and a second portion bound to the analyte. ### Claim 4 (depends on 3) The method according to claim 3 wherein the linker molecule is cleavable. ### Claim 5 (depends on 4) The method according to claim 4 wherein the linker molecule is enzymatically cleavable or photo-cleavable. ### Claim 6 (depends on 4) The method according to claim 4, wherein the linker molecule is a peptide or polypeptide, polysaccharide, double-stranded nucleic acid molecule, or a compound having a photoreactive moiety. ### Claim 7 (depends on 3) The method according to claim 3 wherein the first and second portions of the linker molecule are capable of reversibly binding to one another. ### Claim 8 (depends on 7) The method according to claim 7 wherein the first and second portions each comprise single-stranded nucleic acid molecules capable of hybridizing to one another. ### Claim 9 (depends on 8) The method according to claim 8 wherein release of the analyte comprises heating the analyte-releasing reagent to a temperature close to, at, or above the melting temperature of the nucleic acid molecules of the first and second portions. ### Claim 10 (depends on 7) The method according to claim 7 wherein the first and second portions are molecules that have an affinity for binding to one another. ### Claim 11 (depends on 10) The method according to claim 10 wherein release of the analyte comprises introducing a displacing molecule that has an affinity for the first or second portion of the linker molecule that is greater than the affinity between the first and second portions. ### Claim 12 (depends on 7) The method according to claim 7 wherein the first and second portions are electrochemically associated. ### Claim 13 (depends on 12) The method according to claim 12 wherein release of the analyte comprises adjusting the pH to dissociate the first and second portions. ### Claim 14 (depends on 3) The method according to claim 3 further comprising a polymer coating applied to a surface of the bead, wherein the first portion of the linker molecule is bound directly to the polymer coating. ### Claim 15 (depends on 14) The method according to claim 14 wherein the polymer coating is formed by a polymer selected from the group consisting of polyethylene glycol, dextran, chitosan, acrylamide, cellulose, methacrylate, oxazoline, methacryloxyethyltrimethylammonium, methylpyridine, cinylpyridine, allylamine, butadiene/maleic acid, polyethylene oxide, vinylpyrrolidone, polystyrene, polyvinyl acetate, polyethylenimine, polypropylene, and pullalan. ### Claim 16 (depends on 1) The method according to claim 1, wherein said providing the standard curve is carried out in parallel with said introducing. ### Claim 17 (depends on 1) The method according to claim 1, wherein said providing the standard curve is carried out using one or more containers pre-coated with analyte released by the analyte-releasing reagent. ### Claim 18 (depends on 1) The method according to claim 1 wherein said providing a standard curve is carried out prior to said introducing and detecting. ### Claim 19 (depends on 1) The method according to claim 1 further comprising: first washing the container prior to said detecting, whereby said first washing is effective substantially to remove the one or more cells from the container. ### Claim 20 (depends on 19) The method according to claim 19 wherein said detecting comprises: providing a detection molecule that binds to the analyte and includes a detectable label; and introducing the detection molecule into the container after said first washing. ### Claim 21 (depends on 20) The method according to claim 20 wherein the detectable label is a fluorophore, an enzymatic label, or a radiolabel. ### Claim 22 (depends on 21) The method according to claim 21 wherein said detecting comprises measuring a signal directly caused or indirectly induced by the detectable label bound to the container surface. ### Claim 23 (depends on 19) The method according to claim 19 further comprising: second washing the container after said introducing the detection molecule and prior to said detecting, whereby said second washing is effective substantially to remove from the container the detection molecule that remains unbound to the analyte after said introducing. ### Claim 24 (depends on 1) The method according to claim 1 wherein the provided container further comprises one or more capture molecules bound to the surface, wherein the one or more capture molecules selectively bind to the analyte. ### Claim 25 (depends on 24) The method according to claim 24 wherein the one or more capture molecules are selected from the group consisting of antibodies, antibody mimics, antigens, peptides, proteins, lipids, polysaccharides, oligonucleotides, nucleic acids, protein-binding ligands, receptors, chemical compounds, cell fragments, cellular substructures, synapses, cell organelles, cancer cells, tissue samples, viruses, and bacteria. ### Claim 26 (depends on 1) The method according to claim 1 wherein the analyte is a product secreted or released by a cell or a drug delivery vehicle. ### Claim 27 (depends on 1) The method according to claim 1, wherein the analyte-releasing reagent comprises a plurality of distinct populations of beads to which the analyte is releasably bound, wherein the distinct populations comprises at least three different bead populations loaded with different amounts of the analyte. ### Claim 28 A method of determining release rate of a drug from a drug delivery vehicle, the method comprising: providing a container comprising a surface capable of binding a drug; providing a standard curve for rate of drug release into a container by one or more drug-releasing reagents that comprise a bead and the drug releasably bound to the bead, the container comprising a surface capable of binding the drug; introducing into the provided container a drug delivery vehicle that releases the drug over a period of time; detecting the presence of drug bound to the surface of the container into which the drug delivery vehicle was introduced; and comparing the detected amount of drug to the standard curve to qualify the rate of drug release by the drug delivery vehicle. ### Claim 29 A method of quantifying cellular secretion of an analyte comprising: providing a standard curve for release of an analyte into a first container by one or more analyte-releasing reagents that comprise a bead and the analyte releasably bound to the bead, the first container comprising a surface capable of binding the analyte; introducing one or more cells that secrete the analyte into a second container comprising a surface capable of binding the analyte; detecting the presence of analyte bound to the surface of the second container; and comparing the detected analyte to the standard curve to quantify the amount of analyte released by the one or more cells. ### Claim 30 A method of determining release rate of a drug from a drug delivery vehicle, the method comprising: providing a standard curve for release of a drug into a first container by one or more drug-releasing reagents that comprise a bead and the drug releasably bound to the bead, the first container comprising a surface capable of binding the drug; introducing a drug delivery vehicle that releases the drug over a period of time into a second container comprising a surface capable of binding the drug; detecting the presence of drug bound to the surface of the second container; and comparing the detected amount of drug to the standard curve to qualify the rate of drug release by the drug delivery vehicle.